Cube Labs S.P.A. (IT:CUBE) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Cube Labs, an Italian venture builder in the healthcare technology sector, has secured significant funding for its startups Adamas Biotech and DTech. Adamas Biotech received €425,700 to develop a nutraceutical for intestinal health, while DTech obtained €393,700 for a protective biospray and digital platform. These contributions, backed by the National Biodiversity Future Center, will advance Cube Labs’ innovative healthcare projects.
For further insights into IT:CUBE stock, check out TipRanks’ Stock Analysis page.